Here are three notes:
1. Providence CEO Greg Curhan commented this financing in combination with their recent equity financing allows the company to expand “distribution both across the United States as well as in international markets to deliver innovative spinal technology to help patients enjoy pain-free lives.”
2. The device company develops tissue-sparing devices and instruments for cervical fusions.
3. Spine surgeons, hospitals and ambulatory surgery centers have shown interest in Providence products.
More articles on practice management:
Dr. Scott Gottlieb confirmed as FDA commissioner — 5 insights
Hack may cost Memphis practice $70k — 5 takeaways
Which orthopedists charge for patient no-shows?
